39 results
8-K
EX-99.1
IKT
Inhibikase Therapeutics Inc
30 Apr 24
Regulation FD Disclosure
8:17am
(2) Mild Rash (1) Mild Inhibikase.com : IKT 13
201 TRIAL: EARLY UNBLINDED OBSERVATIONS Functional Assessment: Universal Parkinson’s Disease Rating
424B5
ayclx6p69dkaydt ku5
1 Feb 24
Prospectus supplement for primary offering
4:49pm
424B3
wjlutf necaxoyrt0
4 Apr 23
Prospectus supplement
4:57pm
POS AM
n45858vr m9xz6
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
8-K
EX-99.1
4kcasf36w po3
17 Nov 22
Inhibikase Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Period Activity
4:30pm
8-K
EX-99.1
z1lnx3yl5x5w5a6jc
16 Sep 22
Regulation FD Disclosure
4:09pm